FutureGen

About:

FutureGen is a research and development manufacturer for antibody medication.

Website: http://www.futuregen.com.cn

Top Investors: Lilly Asia Ventures, Sinopharm Capital, MSA Capital, Dyee Capital, Zhongjin Qide

Description:

FutureGen is a biopharmaceutical company that develops innovative biologics. The company works in the fields of immunology and cancer, concentrating on the creation and commercialization of novel biologics. The STEP (Structure-based Targeted Evolution Platform) from FutureGen is a cutting-edge screening platform designed specifically for protein drug screening. It integrates several technologies to quickly screen and produce the best antibodies. FutureGen has experience in medication development, clinical research, CMC, and quality in the business world.

Total Funding Amount:

300M CNY

Headquarters Location:

Changping, Beijing, China

Founded Date:

2014-01-01

Contact Email:

hr(AT)futuregenbiopharm.com

Founders:

Jin Zhaoyu

Number of Employees:

51-100

Last Funding Date:

2021-03-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai